These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

41 related articles for article (PubMed ID: 7781270)

  • 1. Fulminant hepatic failure in association with quetiapine: a case report.
    Al Mutairi F; Dwivedi G; Al Ameel T
    J Med Case Rep; 2012 Dec; 6():418. PubMed ID: 23234465
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of drug-induced tissue injury by measuring alanine aminotransferase (ALT) activity in silkworm hemolymph.
    Inagaki Y; Matsumoto Y; Kataoka K; Matsuhashi N; Sekimizu K
    BMC Pharmacol Toxicol; 2012 Nov; 13():13. PubMed ID: 23137391
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A surveillance method for the early identification of idiosyncratic adverse drug reactions.
    Etwel FA; Rieder MJ; Bend JR; Koren G
    Drug Saf; 2008; 31(2):169-80. PubMed ID: 18217792
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Pharmacological treatment in adults with attention deficit hyperactivity disorder].
    Frölich J; Lehmkuhl G
    Nervenarzt; 2004 Nov; 75(11):1074-82. PubMed ID: 15549216
    [TBL] [Abstract][Full Text] [Related]  

  • 5. European clinical guidelines for hyperkinetic disorder -- first upgrade.
    Taylor E; Döpfner M; Sergeant J; Asherson P; Banaschewski T; Buitelaar J; Coghill D; Danckaerts M; Rothenberger A; Sonuga-Barke E; Steinhausen HC; Zuddas A
    Eur Child Adolesc Psychiatry; 2004; 13 Suppl 1():I7-30. PubMed ID: 15322953
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stimulant drugs.
    Santosh PJ; Taylor E
    Eur Child Adolesc Psychiatry; 2000; 9 Suppl 1():I27-43. PubMed ID: 11140778
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fragile X syndrome.
    Phillips JP; Wilson GA
    Indian J Pediatr; 1998; 65(2):181-91. PubMed ID: 10771963
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug treatment of patients with insomnia and excessive daytime sleepiness: pharmacokinetic considerations.
    Nishino S; Mignot E
    Clin Pharmacokinet; 1999 Oct; 37(4):305-30. PubMed ID: 10554047
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current drug therapy recommendations for the treatment of attention deficit hyperactivity disorder.
    Cyr M; Brown CS
    Drugs; 1998 Aug; 56(2):215-23. PubMed ID: 9711446
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pemoline hepatotoxicity in children.
    Marotta PJ; Roberts EA
    J Pediatr; 1998 May; 132(5):894-7. PubMed ID: 9602211
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pemoline therapy resulting in liver transplantation.
    Adcock KG; MacElroy DE; Wolford ET; Farrington EA
    Ann Pharmacother; 1998 Apr; 32(4):422-5. PubMed ID: 9562136
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of attention-deficit/hyperactivity disorder: overview of the evidence.
    Brown RT; Amler RW; Freeman WS; Perrin JM; Stein MT; Feldman HM; Pierce K; Wolraich ML; ;
    Pediatrics; 2005 Jun; 115(6):e749-57. PubMed ID: 15930203
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pemoline-associated fulminant liver failure: testing the evidence for causation.
    Berkovitch M; Pope E; Phillips J; Koren G
    Clin Pharmacol Ther; 1995 Jun; 57(6):696-8. PubMed ID: 7781270
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiac safety of central nervous system stimulants in children and adolescents with attention-deficit/hyperactivity disorder.
    Winterstein AG; Gerhard T; Shuster J; Johnson M; Zito JM; Saidi A
    Pediatrics; 2007 Dec; 120(6):e1494-501. PubMed ID: 18055666
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pemoline (Cylert): market withdrawal.
    Hogan V
    CMAJ; 2000 Jan; 162(1):106, 110. PubMed ID: 11216184
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.